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Abstract
Background: Geopropolis is a type of propolis containing resin, wax, and soil, collected by threatened stingless bee
species native to tropical countries and used in folk medicine. However, studies concerning the biological activity
and chemical composition of geopropolis are scarce. In this study, we evaluated the antimicrobial and
antiproliferative activity of the ethanolic extract of geopropolis (EEGP) collected by Melipona scutellaris and its
bioactive fraction against important clinical microorganisms as well as their in vitro cytotoxicity and chemical profile.
Methods: The antimicrobial activity of EEGP and fractions was examined by determining their minimum inhibitory
concentration (MIC) and minimum bactericidal concentration (MBC) against six bacteria strains as well as their
ability to inhibit Streptococcus mutans biofilm adherence. Total growth inhibition (TGI) was chosen to assay the
antiproliferative activity of EEGP and its bioactive fraction against normal and cancer cell lines. The chemical
composition of M. scutellaris geopropolis was identified by reversed-phase high-performance liquid
chromatography and gas chromatography–mass spectrometry.
Results: EEGP significantly inhibited the growth of Staphylococcus aureus strains and S. mutans at low
concentrations, and its hexane fraction (HF) presented the highest antibacterial activity. Also, both EEGP and HF
inhibited S. mutans biofilm adherence (p < 0.05) and showed selectivity against human cancer cell lines, although
only HF demonstrated selectivity at low concentrations. The chemical analyses performed suggest the absence of
flavonoids and the presence of benzophenones as geopropolis major compounds.
Conclusions: The empirical use of this unique type of geopropolis by folk medicine practitioners was confirmed in
the present study, since it showed antimicrobial and antiproliferative potential against the cancer cell lines studied.
It is possible that the major compounds found in this type of geopropolis are responsible for its properties.
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Background
Propolis, a resin collected by bees from several plants, pre-
sents a great variety of pharmacological effects already
described in the literature, such as antimicrobial, anti-
inflammatory, immune-modulatory, anti-ulcer, and anti-
tumor properties. Regarding antimicrobial activity, several
types of propolis collected by Apis mellifera seem to be
active against various microorganisms [1]. The variation in
biological activity of different types of propolis is directly
related to their complex chemical composition, which can
vary according to season, region of plant resin collection [2],
and bee species. Most of the studies available in the inter-
national literature, however, are related to propolis collected
by A. mellifera, whereas other types of propolis collected by
different species of bees have been sparsely studied.
Geopropolis is a different kind of propolis because it
presents wax and soil in its constitution, conferring
unique characteristics to it. This type of propolis, collected
by stingless bees, such as Melipona scutellaris, an endan-
gered bee species native to tropical countries, has been
scarcely described in the literature and little is known
about its chemical composition and biological activity.
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Despite being widely used by low income communities in
Brazil, especially in the Northeast Region, this substance is
not a value added product from beekeeping [3].
Velikova et al. [4] described the antimicrobial activity of
samples of Brazilian geopropolis against Staphylococcus
aureus and Escherichia coli, suggesting the presence of
nonpolar compounds that would account for this prop-
erty. Liberio et al. [5] showed that geopropolis from
Maranhão, Brazil, collected by Melipona fasciculate,
presented antimicrobial activity against S. aureus and
Candida albicans, and also exhibited bactericidal effects
against Streptococcus mutans biofilms. Nonetheless, the
antimicrobial activity was attributed only to samples with
the highest flavonoid contents. Given that the geopropolis
collected by this bee species exhibits interesting antimicro-
bial profile, elucidating its biological and chemical charac-
teristics is of fundamental importance to characterize the
potential use of this not fully studied type of propolis as
medicine or functional food.
Bacteria that normally inhabit the oral cavity, such as
S. mutans, Actinomyces naeslundii, and Enterococcus
faecalis, acquire relevant clinical importance in oppor-
tunistic pathogenic situations, since they may be related
to several oral infections. Among these microorganisms,
S. mutans deserves special attention due to its unique
ability to form biofilms, and consequently start the cario-
genic process [6] or endocarditis [7]. Also, bacteria such
as S. aureus, methicillin-resistant S. aureus (MRSA), and
Pseudomonas aeruginosa are often associated with noso-
comial infections and have been showing increased resist-
ance to many available antibiotics [8] stimulating new
approaches for alternative treatments.
Once a natural product is proven to present anti-
microbial activity, it is necessary to know whether it has
compatibility with the normal cells of the host to enable
its possible harmless use. Furthermore, some authors
have studied natural products which act against micro-
organisms and also exhibit antiproliferative activity
against tumor cells, increasing the range of possible uses
for these products [9]. A type of propolis found in the
tropical region and collected by stingless bee species
showed antiproliferative activity in vitro against tumor
but not normal cell lines [10].
Given the lack of scientific information about geopropolis
collected by M. scutellaris, this study aimed to evaluate the
antimicrobial and antiproliferative activity of the ethanolic
extract of geopropolis (EEGP) and its fractions, as well as
characterize them chemically, thereby generating reliable
information that may add value to this natural product.
Methods
Geopropolis sample and fractionation
Crude samples of M. scutellaris geopropolis were
obtained in the city of Entre Rios, in the state of Bahia
(11°57' S, 38°05' W), Northeast Region of Brazil. The
geopropolis sample (100 g) was extracted with absolute
ethanol (1:7, w/v), at 70°C, for 30 min and then filtered
to obtain its ethanolic extract (EEGP). The EEGP was
fractionated by liquid–liquid extraction, based on a po-
larity gradient, and hexane (HF), chloroform (CF), and
ethyl acetate (EAF) fractions were obtained, as previ-
ously detailed by Franchin et al. [11]. The fractions
obtained were monitored by thin layer chromatography
(TLC) using the anisaldehyde reagent, followed by incu-
bation at 100°C for 5 min. The fluorescent substances
were visualized under ultraviolet (UV) light at the wave-
lengths of 254 nm and 366 nm. EEGP, HF, CF, and EAF
were concentrated and yields of 4.33 (w/w), 1.98 (w/w),
0.23 (w/w), and 0.87 (w/w) were obtained, respectively.
EEGP and all the fractions were reconstituted with abso-
lute ethanol to 3.2% (w/v) before further use. Since geo-
propolis presents soil in its composition and this can
contain antimicrobial substances [12], samples of the soil
around the hive underwent the same process of extrac-
tion with absolute ethanol used to obtain EEGP, and had
their antimicrobial activity evaluated.
Bacterial strains and susceptibility testing
The bacterial strains used in this study were: Streptococcus
mutans UA 159, Staphylococcus aureus ATCC 25923,
Staphylococcus aureus ATCC 33592 (methicillin-resistant
Staphylococcus aureus), Enterococcus faecalis ATCC 29212,
Actinomyces naeslundii m104, and Pseudomonas aerugi-
nosa ATCC 25619. The antimicrobial activity of EEGP and
fractions was examined by determining the minimum
inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC), in accordance with the Clinical and
Laboratory Standards Institute (CLSI) guidelines [13]. MIC
was performed in 96-well microplates, inoculated with
5 × 105 CFU/mL, using brain heart infusion medium
(BHI, Difco, Franklin Lakes, NJ, USA), and the concentra-
tions of EEGP and fractions ranged from 3.125 to 1600
μg/mL. The vehicle control was ethanol (final ethanol
concentration: 5%, v/v), and the positive control was
0.12% chlorhexidine digluconate (Sigma-Aldrich, St.
Louis, MO, USA). The plates were incubated at 37°C and
5% CO2 for 24 h and MIC was defined as the lowest con-
centration of EEGP or fraction that allowed no visible
growth, confirmed by 0.01% resazurin dye (Sigma-Aldrich,
St. Louis, MO, USA). MBC was determined by sub-
culturing on BHI agar 50-μL aliquots of each incubated
well that presented concentration higher than the MIC
[14]. Three separate experiments were conducted in tripli-
cates for each concentration of EEGP and fractions.
Inhibition of Streptococcus mutans biofilm adherence
The ability of EEGP and its bioactive fraction (HF) to
inhibit the adherence of S. mutans growing cells was
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tested as described by Castro et al. [15] and Galvão et al.
[16] with some modifications. Briefly, S. mutans cells
(1.0 × 105 CFU/mL in BHI plus 1% sucrose w/v) were
grown in 96-well sterilized polystyrene U-bottom micro-
titer plates containing EEGP or HF at sub-MIC concen-
trations or the vehicle control (5% v/v ethanol). After
incubation at 37°C for 18 h, the adherent cells were
stained with 1% crystal violet aqueous solution (w/v) and
resuspended in absolute ethanol. Biofilm formation was
quantified by measuring the absorbance at 575 nm using
a Biochrom Asys UVM 340 Scanning Microplate Reader
(Asys HiTech GmbH, Cambridge, United Kingdom) and
the ScanPlus 2.0.1 software.
Antiproliferative assay
The in vitro antiproliferative assay was performed
according to Monks et al. [17]. Also, The human kera-
tinocyte cell line HaCaT, kindly donated by Dr. Ricardo
Della Coletta (FOP, UNICAMP, Piracicaba, SP, Brazil),
murine normal fibroblast (3T3) and eight human tumor
cell lines [glioma (U251), melanoma (UACC-62), breast
(MCF-7), multidrug resistant ovarian (NCI-ADR/RES),
kidney (786–0), lung, non-small cells (NCI-H460), pros-
tate (PC-3), and ovarian (OVCAR-03)], kindly provided
by the National Cancer Institute (Frederick, MD, USA),
were used in this study. Stock and experimental cultures
were grown in medium containing 5 mL RPMI 1640
(Gibco BRL, Gaithersburg, MD, USA) supplemented
with 5% fetal bovine serum (Gibco BRL). Peniciline:
streptomicine mixture (1000 U/mL:1000 μg/mL, 1 mL/L
RPMI) was added to the experimental cultures. In 96-well
plates, 100 μL cells/well of each cell line aforementioned
were exposed to EEGP and HF at the concentrations of
0.25, 2.5, 25, and 250 μg/mL in dimethyl sulfoxide
(DMSO)/RPMI, vehicle control, or doxorubicin (Dox)
used as positive control (0.25, 2.5, 25, and 250 μg/mL), at
37°C, 5% CO2 aerobically for 48 h. Final DMSO concen-
tration did not affect cell viability. Before (T0 plate) and
after sample addition (T1 plates), cells were fixed with
50% trichloroacetic acid and cell proliferation was deter-
mined by spectrophotometric quantification (540 nm) of
cellular protein content using the sulforhodamine B assay.
Three measurements were obtained at the beginning of
incubation (time zero, T0) and 48 h postincubation for
compound-free (C) and tested (T) cells. Cell proliferation
was determined according to the equation 100 × [(T-T0)/
C-T0], for T0 < T ≤ C, and 100 × [(T-T0)/T0], for T ≤ T0.
A concentration-response curve was plotted for each cell
line and, from these curves, TGI (concentration that
promotes total growth inhibition) was determined by the
concentration-response curve for each cell line obtained
by non-linear regression analysis using the software
Origin 8.0 (OriginLab Corporation, Inc., Northhampton,
MA, USA).
Chemical assays
Reversed-phase high-performance liquid chromatography
(RP-HPLC)
EEGP was analyzed by reversed-phase high-performance
liquid chromatography (RP-HPLC) using a liquid chro-
matography system (Shimadzu Ltd., Kyoto, Japan) with a
Shimadzu ODS-A column (RP-18, 4.6 mm × 250 mm;
5 μm particle size) and a photodiode array detector
(SPD-M10AVp) at 254 nm. EEGP was filtered through
0.22 mm filter (Millipore) and 20 mL injected into the
HPLC system. The column was eluted by using a linear
gradient of water/acetic acid (19:1, v/v) (solvent A) and
methanol (solvent B) at a constant flow rate of 1 mL/min.
The gradient started with 30% solvent B, changing to 40%
of B in 15 min, 50% of B in 30 min, 60% of B in 45 min,
75% of B in 65 min, 75% of B in 85 min, 90% of B in 95
min, 90% of B in 110 min, and 30% of B in 120 min. The
column was maintained at 35°C. The chemical com-
pounds were identified by their absorption spectra in the
UV region, using the photodiode array detector and com-
parison to authentic standards (p-coumaric acid, ferulic
acid, cinnamic acid, gallic acid, quercetin, kaempferol,
kaempferide, apigenin, sakuranetin, isosakuranetin, pino-
cembrin, chrysin, acacetin, and galangin).
Derivatization – formation of trimethylsilyl derivatives
(TMS)
Prior to gas chromatography–mass spectrometry (GC-
MS) analysis, EEGP underwent the crucial stage of
chemical derivatization, widely used to reduce the po-
larity of functional groups and facilitate their separ-
ation during GC-MS analysis. An aliquot of 10 mg of
EEGP was added to 100 μL of the derivatizing reagent
N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA)
and the reaction mixture was homogenized and incu-
bated at 70°C for 10 min. The reagent was evaporated
under a stream of nitrogen and trimethylsilyl (TMS)
derivatives were rediluted in hexane (800 μL). After
homogenization, the supernatant was transferred to a
vial and injected into the GC-MS system.
Gas chromatography–mass spectrometry (GC-MS)
GC-MS analysis of the derivatized EEGP was performed
using gas chromatography system GC-2010 (Shimadzu
Ltd., Kyoto, Japan), coupled to a mass spectrometer (QP
2010 Plus, Shimadzu Ltd., Kyoto, Japan). The temperature
program started at 60°C (1 min), increasing at 3°C/min to
240°C, remaining at 240°C for 15 min. Helium was used
as the carrier gas, the injector temperature was 280°C, and
the injection volume was 0.5 μL in splitless mode. The
interface was maintained at 280°C and the detector was
operated in the scanning mode (m/z 40–800). Data inte-
gration was performed using the LabSolutions-GCMS
software. Flavonoids, phenolic acids, and derivatives were
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identified by comparing their retention time and ion frag-
mentation with coded and authentic standards (quercetin,
apigenin, kaempferol, kaempferide, rutin, epicatechin, cat-
echin, resveratrol, ferulic acid, caffeic acid, p-coumaric
acid, and cinnamic acid) eluted under the same conditions
as well as with the Wiley Version 8 library [18].
Statistical analysis
The results obtained for inhibition of S. mutans biofilm ad-
herence were compared using Kruskal-Wallis test (p < 0.05
was considered statistically significant). Triplicates from at
least three separate experiments were conducted for each
assay.
Results
Table 1 shows MIC and MBC values for EEGP and frac-
tions against the tested microorganisms. EEGP was able
to inhibit the growth of S. mutans, S. aureus, and MRSA
strains at concentrations lower than 50 μg/mL, while the
growth of E. faecalis and A. naeslundii was inhibited be-
tween 800 and 1600 μg/mL. Neither EEGP nor the frac-
tions inhibited the growth of P. aeruginosa at the tested
concentrations. Except for S. aureus strains, which were
killed between 25 and 50 μg/mL, MBC values showed
that EEGP presented bactericidal activity at concentra-
tions over 1600 μg/mL against the tested microorgan-
isms. The extract of the soil obtained from the region of
geopropolis collection showed the same antimicrobial
profile of the vehicle, thus not interfering with the
growth of the tested microorganisms.
The geopropolis fractions were tested to observe
whether the chemical separation process was able to re-
duce their MIC values in relation to EEGP. Table 1
shows that, compared to EEGP, HF (nonpolar) presented
lower or equal MIC values for S. mutans, S. aureus, and
MRSA strains, and for E. faecalis and A. naeslundii, this
value was reduced to 100–200 μg/mL and 200–400 μg/mL,
respectively.
Figure 1 shows that both EEGP and HF were able to
significantly decrease (p < 0.05) S. mutans biofilm
formation. The lowest concentrations of EEGP and HF
that significantly reduced the biofilm formation were
25 and 6.25 μg/mL, respectively. EEGP showed inhib-
ition rate of 51% at 25 μg/mL, whereas HF showed
inhibition rate of 86% at 6.25 μg/mL compared to the
vehicle control.
Table 2 shows the antiproliferative activity of EEGP
and HF against normal and tumor human cell lines.
EEGP presented more activity against tumor cell lines,
inhibiting the total growth at low concentrations when
compared to normal lines. All tumor cell lines tested
were inhibited by EEGP at concentrations below 35 μg/mL,
whereas the normal cell lines (HaCaT and 3T3) were
inhibited over 40 μg/mL (43.20 and 52.73 μg/mL, re-
spectively). The lowest TGI value for EEGP was observed
against melanoma tumor cells (10.90 μg/mL). The TGI
values obtained for HF were lower than 15.00 μg/mL for
most of the cell lines tested and 32.00 μg/mL for HaCaT.
HF was also more selective regarding the melanoma line,
since the TGI was 1.77 μg/mL, about six times lower than
that registered for EEGP.
The chemical assays were performed for EEGP and
HF. The chromatograms obtained by RP-HPLC analyses
of EEGP and HF, shown in Figure 2A and B, respect-
ively, demonstrated the presence of similar peaks, how-
ever more concentrated in the bioactive fraction (B). No
patterns of flavonoid or cinnamic acid derivatives were
detected, considering the detection limit of the method.
The UV spectrum showed that the major compounds
observed, 4, 5, and 7 (Figure 2), have similar λmax at 279,
281, and 282 nm, respectively.
Table 3 shows the compounds identified in EEGP and
HF by GC-MS analyses. Most of the substances could
not be identified based on the library device, thus con-
firming the absence of phenolic acid and flavonoid pat-
terns within the detection limit of the method used.
Compounds 3 and 4 showed M+ at m/z 591, and some
fragments at m/z 589, 445, and 73, although with differ-
ent base peaks (73 and 501, respectively). Moreover,
both compounds were more concentrated in the
Table 1 Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of the
ethanolic extract of geopropolis (EEGP) and its fractions (hexane – HF; chloroform – CF; ethyl acetate – EAF) against
the tested microorganisms (values in μg/mL)
Microorganism EEGP HF CF EAF
MIC MBC MIC MBC MIC MBC MIC MBC
Streptococcus mutans UA 159 25–50 a 6.25–12.5 800–1600 25–50 a a a
Staphylococcus aureus ATCC 25923 6.25–12.5 25–50 6.25–12.5 25–50 12.5–25 50–100 50–100 100–200
Staphylococcus aureus ATCC 33592 (MRSA) 6.25–12.5 25–50 12.5–25 25–50 6.25–12.5 25–50 25–50 50–100
Enterococcus faecalis ATCC 29212 800–1600 a 100–200 800–1600 400–800 a 400–800 a
Actinomyces naeslundii m104 800–1600 a 200–400 800–1600 400–800 a 400–800 a
Pseudomonas aeruginosa ATCC 25619 a a a a a a a a
a Value > 1600 μg/mL.
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nonpolar fraction (HF), with relative areas of 9.54% and
8.40%. Furthermore, compounds 8 and 9 showed the
same M+ (m/z 623), similar retention times, and the
same fragment m/z 105 ([C6H5CO]
+), as well as com-
pound 6. Also, the fragment ions of m/z 77, 69, and 55
were observed in compound 6, while compounds 8 and
9 showed fragments m/z 69 and 77, respectively. Com-
pound 8 was the most abundant one found in EEGP and
HF, and compound 9 was more concentrated in EEGP
compared to HF. According to the results of HPLC, no
flavonoids were found.
Discussion
Propolis, a resin collected by bees, exhibits a consider-
able variety of well-established pharmacological activ-
ities, and its antimicrobial potential has been widely
studied, especially against oral pathogens [1,14,15,19].
Most of these studies describe the activity of propolis
collected by A. mellifera, which increased the market
price of this product. Geopropolis is a type of propolis
collected by stingless bee species native to tropical coun-
tries, which, in addition to resin and wax, has soil in its
composition, leading to low yield extracts, a fact that
can partly justify its low economic value and the lack of
studies on its biological activity [3].
In this study, EEGP showed interesting antimicrobial
activity, especially against S. aureus, S. mutans, and
MRSA strains, with MIC values below 50 μg/mL, but it
presented weak inhibition of P. aeruginosa growth, a
Gram-negative bacillus. Our findings are corroborated
by Velikova et al. [4], who reported that Brazilian geo-
propolis samples showed significant activity against S.
aureus but presented weak activity against E. coli, as well
as by Duarte et al. [20], who affirmed that crude extracts
from natural products are considered promising when
the MIC value is below 500 μg/mL.
Figure 1 Effect of the ethanolic extract of geopropolis (EEGP) and its hexane fraction (HF) to inhibit the adherence of Streptococcus
mutans UA159 growing cells. Each concentration marked with * differs significantly from the vehicle control (p < 0.05, ANOVA, Student-
Newman-Keuls).
Table 2 Total growth inhibition (TGI) of the ethanolic
extract of geopropolis (EEGP), its hexane fraction (HF),
and the positive control doxorubicin (Dox) on human
normal and tumor cell lines
Cell line TGI (μg/mL)
EEGP HF Dox
Keratinocytes (HaCaT)a 43.20 32.00 0.96
Murine normal fibroblast (3T3)a 52.73 12.27 0.92
Glioma (U251) 21.18 7.17 1.08
Melanoma (UACC-62) 10.90 1.77 0.22
Breast (MCF-7) 26.41 14.09 2.19
Multidrug resistant ovarian (NCI/ADR-RES) 23.92 14.34 6.19
Kidney (786–0) 32.26 8.45 1.51
Lung (NCI-H460) 26.72 9.55 0.67
Prostate (PC-3) 20.54 5.96 1.15
Ovarian (OVCAR-3) 11.93 3.93 3.78
a Normal cell lines.
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Several types of A. mellifera propolis extracts have
their activity against S. mutans well described in the lit-
erature. Duarte et al. [21] showed that the ethanolic ex-
tract of Brazilian propolis type 6 inhibited S. mutans UA
159 growth at concentrations between 25 and 100 μg/mL
and Hayacibara et al. [19] reported that Brazilian propolis
types 3 and 12 were able to inhibit bacterial growth at
25–50 μg/mL and 200–400 μg/mL, respectively. EEGP
inhibited the growth of S. mutans UA 159 between 25
and 50 μg/mL, also demonstrating strong inhibitory ac-
tivity with bacteriostatic character, suggesting its ability
to act on the virulence factors of the microorganisms
involved in the etiology of dental caries. In case of an
infection in the oral cavity, actions that have impact on
the virulence factor of the microorganisms seem to be
the best way to control their development and patho-
genesis, since total and permanent elimination of bac-
teria from the oral environment is not viable [22]. Such
effect of geopropolis, provided that it is confirmed by
specific studies, indicates the presence of compounds
that can be effective in controlling and preventing car-
ies. S. aureus and MRSA infections have acquired great
clinical importance, because these organisms appear to
be resistant to β-lactam, aminoglycoside, and macrolide
antibiotics as well as to certain antiseptic substances
[23]. In the present study, EEGP demonstrated to be a
promising source of bioactive compounds against this
pathogen, showing the lowest MIC and MBC values
Figure 2 RP-HPLC chromatograms. Chromatogram of the ethanolic extract of geopropolis (EEGP) (A) and its hexane fraction (HF) (B) using
photodiode array detector (SPD-M10AVp) at 254 nm; reversed-phase C18 column (250 mm × 4.6 mm i.d.; 5 μm particle size); mobile phase:
water/acetic acid (19:1, v/v) (solvent A) and methanol (solvent B) at a constant flow rate of 1 mL/min. The gradient started with 30% solvent B,
changing to 40% of B in 15 min, 50% of B in 30 min, 60% of B in 45 min, 75% of B in 65 min, 75% of B in 85 min, 90% of B in 95 min, 90% of B
in 110 min, and 30% of B in 120 min. The column was maintained at 35°C. Constituents are represented only by the absorption spectra in the UV
(λmax): 1: UV λ 241 nm, RT = 2.72 min; 2: UV λ 287 nm, RT = 81.40 min; 3: UV λ 283 nm, RT = 83.31 min; 4: UV λ 279 nm, RT = 100.53 min;
5: UV λ 281 nm, RT = 101.95 min; 6: UV λ 240 nm, RT = 42.54 min; 7: UV λ 282 nm, RT = 87.14 min; 8: UV λ 284 nm, RT = 91.00 min.
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against both S. aureus strains tested. Furthermore,
when compared to other strains, MRSA was the most
sensitive microorganism, with all fractions tested show-
ing low MIC and MBC values.
In order to verify whether the chemical separation was
efficient, HF, CF, and EAF were tested against the same
microorganisms and their MIC values were compared to
the values obtained for EEGP. HF proved to be the most
potent fraction, reducing MIC and MBC values (between
two to four times) for S. mutans, E. faecalis, and A. nae-
slundii, and maintaining these values against S. aureus
25923 compared to EEGP. Against MRSA, HF was less
active than EEGP and CF. In general, all the other frac-
tions showed low bacterial growth inhibition compared
to HF and EEGP. Such effect suggests that nonpolar
compounds present in geopropolis should be the main
substances responsible for its biological activity.
EEGP and HF (defined as the most active fraction) were
also able to inhibit the adherence of S. mutans growing
cells at sub-MIC concentrations. The inhibition rates
observed indicate that HF probably presents higher 2activ-
ity than EEGP because of a concentration of bioactive
compounds in the nonpolar fraction, which suggests that
this fraction might contain promising anti-caries agents.
Other types of Brazilian propolis also showed this antibio-
film activity with a similar mechanism of action, especially
Brazilian propolis type 6, which presented activity against
adherence of S. mutans growing cells due to its activity on
glucan synthesis by inhibiting glucosyltransferases [14].
Furthermore, other kinds of geopropolis collected by other
bee species and from different regions demonstrated similar
mechanisms of action against S. mutans, reducing the cell
viability of the biofilm formed by this microorganism [5].
According to Fouche et al. [24], extracts of natural pro-
ducts with antiproliferative activity can be classified as
inactive (TGI > 50 μg/mL), presenting weak activity
(15 μg/mL < TGI < 50 μg/mL), moderate activity
(6.25 μg/mL < TGI < 15 μg/mL), and potent activity (TGI
< 6.25 μg/mL). EEGP was inactive against normal mur-
ine fibroblast cells and a weak inhibitor of human kera-
tinocytes. Among the human cancer cell lines tested,
EEGP showed moderate inhibition against melanoma
and ovarian cancer lines. These results indicate that
EEGP exhibited a nontoxic profile against normal cell
lines and toxicity against cancer cell lines, i.e., a select-
ive antiproliferative activity. Additionally, HF main-
tained the weak activity against HaCaT cells, promoted
a six-fold reduction in TGI value against the melanoma
line compared to EEGP, and presented potent activity
against prostate and ovarian tumors.
Umthong et al. [10] described the selective antiproli-
ferative activity of propolis collected by Trigona laevi-
ceps, a stingless bee species, against some cancer cell
lines and low cytotoxic activity against normal cell lines.
Comparatively, M. scutellaris geopropolis seems to be a
promising source of anti-tumor bioactive compounds,
showing moderate or strong inhibition of a wide range
of cell lines. Although these are preliminary results
obtained from in vitro evaluations, they indicate that the
compounds present in EEGP and HF could be used to
treat some types of infections and tumors without caus-
ing significant damage to the normal cells tested here. In
fact, the concentrations of EEGP and HF that can affect
the normal cell lines were higher than those effective
against some bacteria or tumor cell lines.
RP-HPLC analyses confirmed the presence of low po-
larity compounds in M. scutellaris geopropolis, evi-
denced by high elution times (RT between 80 and 120
min), corresponding to less polar compounds, and also
by the concentration of substances in HF. Other types of
propolis and Brazilian geopropolis are essentially nonpo-
lar due to the presence of terpenes and benzophenones
Table 3 Kovats retention index (RI), retention times (RT), concentration of each component (relative area), and
important ions present in the mass spectra of compounds of the identified compounds in the ethanolic extract of
geopropolis (EEGP) and its hexane fraction (HF) by gas chromatography–mass spectrometry (GC-MS)
Compound RI RT (min) Relative area (%) Major MS peaks: m/z
EEGP HF
2-propensaeure 3-phenyl-trimethylsilylester 1542 17.84 8.91 3.92 220, 205, 161, 145, 131, 103, 77
1,2-benzenedicarboxylic acid 2543 36.60 NDa 2.24 167, 149, 57
3 – 43.06 0.68 9.64 591, 589, 499, 445, 73
4 – 43.79 6.88 8.40 591, 589, 501, 459, 445, 73, 57
5 – 46.38 3.34 9.06 533, 386, 177, 165, 151, 138, 105, 77, 69, 55
6 – 46.94 5.79 2.30 495, 459, 417, 105, 77, 73, 69, 57, 55
7 – 47.29 19.17 10.35 548, 533, 479, 389, 73, 45
8 – 47.71 29.15 38.98 623, 536, 535, 105, 73, 69
9 – 47.91 6.93 4.76 623, 533, 551, 461, 407, 105, 77, 73
a Non detected compound.
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[4]. The UV spectra of the major compounds (4, 5, and
7, Figure 2) ranged from λmax 279 to 282 nm, suggesting
a possible chromophore with characteristics of polypre-
nylated benzophenones [25]. Our findings also indicate
the absence of flavonoids, usually reported as respon-
sible for the pharmacological activities attributed to
some types of A. mellifera propolis, as well as of markers
of some types of propolis [3,26].
CG-MS data showed the presence of compounds
belonging to similar chemical classes, indicated by the
fragmentation pattern of the mass spectra. The fragment
at m/z 105 [(C6H5CO)
+], observed in the fragmentation
pattern of compounds 6, 8, and 9, suggests that they
have characteristics of the class of benzophenones, and
the presence of fragments at m/z 55, 69, and 77 indi-
cates that they present prenylations [27]. These findings
about the chemical profile of M. scutellaris geopropolis
corroborate the differentiated profile and the not yet en-
tirely elucidated nature of its bioactive compounds. This
stimulates the search for a detailed description of its
chemical composition and the potential use of its bio-
active compounds as complementary food or medicine,
thus increasing the economic and social value of a nat-
ural product not fully recognized.
The presence of benzophenones, especially polypreny-
lated ones, has been described in some types of propolis.
Ishida et al. [25] attributed the antimicrobial activity of
propolis samples from the Brazilian Amazon region to
benzophenones, such as epi-nemorosone and 7-epi-
clusianone, which are also described as typical metabolites
produced by Clusiaceae (Guttifarae), a family of plants
widely distributed in Brazil. Studies on the chemical com-
position and biological activity of Brazilian propolis type 6,
collected by A. mellifera in the state of Bahia, showed cer-
tain similarities to the geopropolis studied herein, from
the same state, although they were collected by bees with
completely different biological characteristics [21,28].
The studies reported that Brazilian propolis type 6 has
an essentially nonpolar composition, showing the pos-
sible presence of benzophenones and the absence of
phenolic acids and flavonoids [21,28]. Similarly to the
geopropolis of the present study, HF was the fraction
responsible for the best activity of Brazilian propolis
type 6, and its biological activity was attributed to
hyperibone A, which also acts against the adherence of
S. mutans biofilm [15]. The similarities between the
chemical and biological profiles of geopropolis collected
by M. scutellaris and Brazilian propolis type 6 suggest
that the possible activity of the former is due to the
presence of a benzophenone.
Conclusion
Geopropolis collected by M. scutellaris presented inter-
esting antimicrobial and antiproliferative activity. Also, it
proved to be a promising source of antibiofilm agents
and to present selectivity against human cancer cell lines
at low concentrations compared to normal cells. Its
chemical composition appears to be essentially nonpolar,
which is confirmed by the concentration of its activity in
low polarity fractions. Moreover, the characteristics evi-
denced by the chemical analyses suggest the presence of
benzophenones as active compounds. Therefore geopro-
polis seems to be a promising natural product to be thor-
oughly studied in order to reveal new molecules with
therapeutic properties, since its chemical profile has not
been fully described and its pharmacological potential has
just begun to be unveiled and deserves further studies.
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